SCHEMBL587594

SCHEMBL587594

C=C(OC(=C)C(C)CC)C(C)CC

nearest known ligand 0.39

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21725168 1.00 TSHR (0.35) TSHR
SCHEMBL13461482 0.80
SCHEMBL8386092 0.80
SCHEMBL800009 0.74 MAPK1 (0.31)
SCHEMBL15253481 0.73 TSHR (0.32) TSHR
SCHEMBL676667 0.73
SCHEMBL10224660 0.72 ALDH1A1 (0.33) TSHR
SCHEMBL27610300 0.72
SCHEMBL12340164 0.71
SCHEMBL19590961 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3152620-B1 PASSIVATION LAYER COMPRISING A PHOTOCROSSLINKED FLUOROPOLYMER CHEMOURS CO FC LLC (US) 2018-08-01 EP claimed
US-20180360029-A1 RESIN PRODUCT AND MEDICINAL COMPONENT DISPENSING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-12-20 US disclosed
EP-3385332-A1 RESIN PRODUCT AND MEDICINAL COMPONENT DISPENSING DEVICE Sumitomo Chemical Company, Limited (JP) 2018-10-10 EP disclosed
US-10005103-B2 Method for producing finely structured surfaces LEIBNIZ-INSTITUT FUER NEUE MATERIALIEN GEMEINNUETZIGE GMBH (DE) 2018-06-26 US disclosed
US-20130101796-A1 Method for Producing Finely Structured Surfaces BASF SE (DE) 2013-04-25 US disclosed
EP-2416810-A1 USE OF HOLLOW BODIES FOR PRODUCING WATER-ABSORBENT POLYMER STRUCTURES Evonik Stockhausen GmbH (DE) 2012-02-15 EP disclosed
WO-2010115671-A1 USE OF HOLLOW BODIES FOR PRODUCING WATER-ABSORBENT POLYMER STRUCTURES EVONIK STOCKHAUSEN GMBH (DE) 2010-10-14 WO disclosed
EP-2114365-B1 CATIONIC CONDITIONING AGENT BASF SE (DE) 2010-09-01 EP disclosed
EP-2114365-A1 CATIONIC CONDITIONING AGENT BASF SE (DE) 2009-11-11 EP disclosed
WO-2008092933-A1 CATIONIC CONDITIONING AGENT BASF SE (DE) 2008-08-07 WO disclosed
EP-1468059-A2 RADIATION-HARDENED COATINGS WITH IMPROVED ADHESIVE STRENGTH BASF AKTIENGESELLSCHAFT (DE) 2004-10-20 EP disclosed
WO-2003060029-A2 RADIATION-HARDENED COATINGS WITH IMPROVED ADHESIVE STRENGTH BASF AKTIENGESELLSCHAFT (DE) 2003-07-24 WO disclosed
EP-0945764-B1 Photoresist composition SUMITOMO CHEMICAL CO (JP) 2003-06-18 EP disclosed
WO-2002068549-A2 COATING SLIPS FOR INKJET PRINTING BASF AKTIENGESELLSCHAFT (DE) 2002-09-06 WO disclosed
US-6258507-B1 UNSATURATED AROMATIC ACRYLATED ESTER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-07-10 US disclosed
EP-0945764-A2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-09-29 EP disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180360029-A1 RESIN PRODUCT AND MEDICINAL COMPONENT DISPENSING DEVICE SAMM50, EXOSC9, ATP5ME TSHR 4393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.